Crain's New York Business

Pfizer solos amid mergers
Continued success hinges on product development

In a front page article in Crain's New York Business by Barbara Benson regarding Pfizer's R&D pipeline successes PGI's president was sourced for support and quoted to say:

"Research has been Pfizer's strength. They focused years ago on their R&D strategy, and they've done a good job at it," says
Jan Buck, chairman of Princeton Group International, a pharmaceutical industry consultant of pharmaceutical of Princeton Group International.

Back to Front Page